Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Appointed director
Inv. presentation
Quarterly results
|
|
Amneal Pharmaceuticals, Inc. (AMRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Sold 29,302 shares
@ $4.1267, valued at
$120.9k
|
|
| 08/11/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/09/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/04/2023 |
8-K
| Quarterly results |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 11,571 shares
@ $3.1, valued at
$35.9k
Exercised 23,095 restricted stock units
@ $0 |
|
| 05/19/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 05/12/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/11/2023 |
4
| MEISTER PAUL M (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 107,034 restricted stock units
@ $0
Exercised 112,179 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| Alva Emily Peterson (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| Autor Deborah M. (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| Kiely John (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| Yanai Shlomo (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| Patel Gautam (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| George Jeffrey P. (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| Nark Ted C (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/05/2023 |
8-K
| Quarterly results |
| 04/17/2023 |
8-K
| Quarterly results |
| 03/24/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/24/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/14/2023 |
4
| Konidaris Tasos (Executive Vice President & CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Exercised 87,719 restricted stock units
@ $0 |
|
| 03/07/2023 |
4
| Shah Nikita (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 18,064 shares
@ $1.92, valued at
$34.7k
Exercised 36,232 restricted stock units
@ $0
Granted 183,486 restricted stock units
@ $0
Granted 366,972 options to buy
@ $0 |
|
| 03/07/2023 |
4
| Konidaris Tasos (Executive Vice President & CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Exercised 45,289 restricted stock units
@ $0
Granted 229,358 restricted stock units
@ $0
Granted 458,716 options to buy
@ $0 |
|
| 03/07/2023 |
4
| Patel Chintu (Co-CEO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 733,944 options to buy
@ $0 |
|
| 03/07/2023 |
4
| Patel Chirag K. (President & Co-CEO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 733,944 options to buy
@ $0 |
|
| 03/07/2023 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 19,685 shares
@ $1.92, valued at
$37.8k
Exercised 39,251 restricted stock units
@ $0
Granted 198,777 restricted stock units
@ $0
Granted 397,554 options to buy
@ $0 |
|
| 03/07/2023 |
4
| Daly Jason B. (SVP, Chief Legal Officer) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 8,164 shares
@ $1.92, valued at
$15.7k
Exercised 22,645 restricted stock units
@ $0
Granted 152,905 restricted stock units
@ $0
Granted 305,810 options to buy
@ $0 |
|
| 03/02/2023 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 03/02/2023 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
|
|
|